IRIS Institutional Research Information System - OPENBS Open Archive UniBS

COLLO, LUIGIA RINALDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.967
EU - Europa 2.341
AS - Asia 1.299
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 8
AF - Africa 1
Totale 7.636
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.948
CN - Cina 665
PL - Polonia 661
UA - Ucraina 587
SG - Singapore 287
IT - Italia 274
DE - Germania 221
FI - Finlandia 144
HK - Hong Kong 132
IE - Irlanda 91
FR - Francia 89
GB - Regno Unito 89
TR - Turchia 87
RU - Federazione Russa 78
IN - India 49
CH - Svizzera 37
VN - Vietnam 34
BE - Belgio 22
CA - Canada 15
ID - Indonesia 15
IR - Iran 15
CZ - Repubblica Ceca 13
AU - Australia 11
NL - Olanda 11
EU - Europa 9
SE - Svezia 7
ES - Italia 6
KR - Corea 4
BR - Brasile 3
AR - Argentina 2
EC - Ecuador 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MX - Messico 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
LV - Lettonia 1
MY - Malesia 1
PA - Panama 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
Totale 7.636
Salva come PNG Salva come JPEG
Città #
Warsaw 661
Woodbridge 481
Fairfield 463
Jacksonville 434
Houston 280
Ashburn 269
Singapore 256
Ann Arbor 240
Cambridge 231
Chandler 229
Seattle 201
Princeton 177
Wilmington 174
Nanjing 139
Beijing 132
Hong Kong 128
Dearborn 98
Brescia 92
Dublin 91
New York 89
Istanbul 82
Helsinki 70
Nanchang 54
Des Moines 37
Hebei 37
Jiaxing 36
Moscow 36
Basel 35
Milan 35
Dong Ket 34
Shenyang 34
Changsha 29
Tianjin 26
Jinan 25
Shanghai 25
San Donà Di Piave 24
San Diego 20
Brussels 19
Jakarta 15
Leawood 15
London 15
Pune 15
Hangzhou 14
Hefei 14
Kunming 14
Lancaster 13
San Mateo 13
Brno 12
San Francisco 12
Boardman 11
Teramo 11
Lanzhou 10
Munich 10
Ningbo 10
Norwalk 9
Rome 9
Toronto 9
Ardabil 8
Augusta 8
Taizhou 8
Verona 8
Zhengzhou 8
Assemini 7
Changchun 7
Fuzhou 7
Haikou 6
Canberra 5
Los Angeles 5
Melbourne 5
Monmouth Junction 5
Orange 5
Phoenix 5
Romola 5
Sarezzo 5
Somma Lombardo 5
Taiyuan 5
Chicago 4
Guangzhou 4
Madrid 4
Mumbai 4
New Bedfont 4
Redmond 4
Trento 4
Trieste 4
Allison Park 3
Bari 3
Bologna 3
Genoa 3
Hanover 3
Hof 3
Kocaeli 3
Mondovì 3
Ottawa 3
São Paulo 3
West New York 3
Xian 3
Acton 2
Almaty 2
Altamura 2
Amman 2
Totale 5.947
Salva come PNG Salva come JPEG
Nome #
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 267
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 257
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 217
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 212
Ketamine enhances structural plasticity in human dopaminergic neurons: Possible relevance for treatment-resistant depression 183
Structural plasticity induced by ketamine in human dopaminergic neurons as mechanism relevant for Treatment-Resistant Depression 141
Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels 129
Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine 128
(2 R,6 R)-Hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans 127
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 125
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 120
Pluripotent Stem Cell Based Cultures to Study Key Aspects of Human Cerebral Cortex Development 118
P2X1 receptor activation in HL60 cells. 114
Ketamine increases the expression of GluR1 and GluR2 α-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cells 112
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 110
Ketamine effects on mammalian target of rapamycin signaling in the mouse limbic system depend on functional dopamine D3 receptors 110
Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs. 109
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 107
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 107
An antagonist-insensitive P2X receptor expressed in epithelia and brain 104
ATP mediated cytotoxicity in microglial cells. 103
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling 103
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 101
The NMDA/D1 receptor complex as a new target in drug development 101
Tissue distribution of the P2X7 receptor 99
P2X receptors: an emerging channel family. 98
Purinoceptors in the central nervous system 97
A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: Focus on dopaminergic system 97
Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. 96
Blockade of human P2X7 receptor function with a monoclonal antibody. 92
Immature neuronal phenotype derived from mouse skin precursor cells differentiated in vitro. 91
Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. 86
Alphα6-containing nicotinic acetylcholine receptors mediate nicotine-induced structural plasticity in mouse and human iPSC-derived dopaminergic neurons 83
Neuroadaptation mechanisms to nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor and nicotinic acetylcholine receptors. 82
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 81
Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential 80
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 79
A new isoform of the laminin receptor α7β1 is developmentally regulated in skeletal muscle. 77
Nicotine produces structural plasticity of mesencephalic dopaminergic neurons via activation of Akt-mTor pathway 77
Ketamine produces structural plasticity of mouse mesencephalic dopaminergic neurons via activation of Akt-mTOR pathway: role of dopamine D3 receptor. 77
Human iPS cell-derived dopaminergic neurons reveal role for D3 receptors and mTOR in induction of structural plasticity by antiparkinson DA agonists 76
CRISPR targeting of human induced pluripotent stem cells (HIPSCS) for lineage tracing of HIPSCS-derived neural stem cells during cortical development in vitro 76
Dopamine D3 receptor and beta-2 containing nicotinic acetylcholine receptor are critical in mediating nicotine effects on dopaminergic neurons morphology 75
Critical role of dopamine D3 receptor in structural plasticity generated by exposure to drugs of addiction in mesencephalic dopaminergic neurons 75
Neurotrophic effects of cocaine on mouse mesencephalic dopaminergic neurons are mediated by dopamine D3 receptors 74
Ketamine produces structural plasticity in dopaminergic neurons via co-activation of MEK-ERK and Akt-mTOR pathways: translation from mouse primary culture to human iPSC-derived neurons 74
Attenuated acute effects of ketamine on mTOR pathway in the limbic system of dopamine D3 receptor knock-out mice 74
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 73
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 73
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 73
Morphogenetic changes produced by cocaine and nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor 73
Distictive functions of a6b4 and other integrins in epithelial cells. 72
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 72
Testing the effect of dopamine agonists and of drugs of addiction on structural plasticity of dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 72
Ketamine produces structural plasticity in dopaminergic neurons in vitro via co-activation of MEK-ERK and Akt-mTOR pathways: role of BDNF and dopamine D3 receptor 72
Selective dopaminergic alpha-synuclein pathological changes following glucose deprivation "in vitro": implications for Parkinson's disease 71
Gradient of integrin α6A expession in the myocardium during early heart development. 70
Alpha-synuclein aggregation in dopaminergic cells is modulated by glucose metabolism 69
Cell-type specific integrin variants with alternative α chain cytoplasmic domain 68
Dopamine agonists produce neurotrophic effects on mesencephalic dopaminergic neurons via dopamine D3 receptor activation 68
Distinct alpha7A-beta1 and alpha7B-beta1 integrin expression patterns during mouse development: alpha7A is restricted to skeletal muscle but alpha7B is expressed in striated muscle, vasculature, and nervous system. 67
Differential onset of expression of alpha7 and beta1D integrins during mouse heart and skeletal muscle development. 67
Nicotine enhances the neuroplasticity of dopamine neurons: role of dopamine D3 receptors and acetylcholine nicotinic receptors. 67
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 67
Testing drugs for structural plasticity in dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 66
D3 receptor involvement in neurotrophic effects of amphetamine and cocaine on mesencephalic dopaminergic neurons 64
Effetti neurotrofici dei farmaci agonisti preferenziali D3 sui neuroni mesencefalici: implicazioni terapeutiche per la malattia di Parkinson. 63
Evidence for soluble Interleukin-2 receptor (IL-2) as immunosuppressive factor. 61
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. 60
The integrin alpha6beta4 in epithelial and carcinoma cells 60
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 59
Myogenic conversion of NIH3T3 cells by exogenous MyoD family members: dissociation of terminal differentiation from myotube formation. 58
Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings 58
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 57
Nicotine enhances structural plasticity in mesencephalic dopaminergic neurons: involvement of dopamine D3 receptors and nicotinic acetylcholine receptors. 57
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 57
Long-term expansion of dopaminergic progenitors from human induced pluripotent stem cells (iPSCs) and differentiation into dopaminergic neurons in vitro and in vivo 56
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 56
Neuroprotective effects of D2/D3 agonists in an "in vitro" model of dopaminergic degeneration 55
Oxide Nanowires for Neuron Adhesion and Growth 54
Nicotine produces neurotrophic effects on mesencephalic dopaminergic neurons: role of dopamine D3 receptors and nicotinic acetylcholine receptors 53
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons 53
Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. 51
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons. 51
Involvement of nicotinic acetylcholine receptors and dopamine D3 receptors in structural plasticity of dopaminergic neurons 51
Loss of Synaptic D1 Dopamine/N-Methyl-D-aspartate Glutamate Receptor Complexes in L-DOPA-Induced Dyskinesia in the Rat. 50
Downregulation of dopamine D1/NMDA receptor complexes in the post synaptic densities of dyskinetic rats 50
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. 46
Meccanismo molecolari e cellulari nel Morbo di Parkinson 43
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 42
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 37
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist 32
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 15
Synergic action of L-acetylcarnitine and L-methylfolate in Mouse Models of Stress-Related Disorders and Human iPSC-Derived Dopaminergic Neurons 14
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 12
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 12
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 10
Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine 10
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 9
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 8
Totale 8.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.356 0 0 0 0 0 255 208 234 135 298 100 126
2020/20211.348 28 143 30 159 93 136 61 151 180 121 189 57
2021/2022667 62 140 4 18 9 19 30 43 30 75 54 183
2022/2023627 93 3 10 54 57 187 4 64 106 0 15 34
2023/2024651 41 10 52 53 32 147 28 23 131 17 14 103
2024/2025593 2 40 24 253 157 117 0 0 0 0 0 0
Totale 8.005